To elucidate the clinical potential of KEAP1-mediated PD-L1 expression, we conducted IHC staining and analysis on tissue microarrays (TMAs) comprising lung cancer and corresponding adjacent normal tissues from non-small cell lung cancer (NSCLC) patients (Figure S7). This evidence concerns the gene KEAP1 and non-small cell lung carcinoma.